Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells.

MLA

Maeyouf, Khadeejah, et al. “Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells.” Pharmaceutics, vol. 15, no. 11, Nov. 2023, p. 2643. EBSCOhost, https://doi.org/10.3390/pharmaceutics15112643.

APA

Maeyouf, K., Sakpakdeejaroen, I., Somani, S., Meewan, J., Ali-Jerman, H., Laskar, P., Mullin, M., MacKenzie, G., Tate, R. J., & Dufès, C. (2023). Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells. Pharmaceutics, 15(11), 2643. https://doi.org/10.3390/pharmaceutics15112643

Chicago

Maeyouf, Khadeejah, Intouch Sakpakdeejaroen, Sukrut Somani, Jitkasem Meewan, Hawraa Ali-Jerman, Partha Laskar, Margaret Mullin, Graeme MacKenzie, Rothwelle J. Tate, and Christine Dufès. 2023. “Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells.” Pharmaceutics 15 (11): 2643. doi:10.3390/pharmaceutics15112643.